Literature DB >> 28149967

3D Deep Learning for Multi-modal Imaging-Guided Survival Time Prediction of Brain Tumor Patients.

Dong Nie1, Han Zhang2, Ehsan Adeli2, Luyan Liu2, Dinggang Shen2.   

Abstract

High-grade glioma is the most aggressive and severe brain tumor that leads to death of almost 50% patients in 1-2 years. Thus, accurate prognosis for glioma patients would provide essential guidelines for their treatment planning. Conventional survival prediction generally utilizes clinical information and limited handcrafted features from magnetic resonance images (MRI), which is often time consuming, laborious and subjective. In this paper, we propose using deep learning frameworks to automatically extract features from multi-modal preoperative brain images (i.e., T1 MRI, fMRI and DTI) of high-grade glioma patients. Specifically, we adopt 3D convolutional neural networks (CNNs) and also propose a new network architecture for using multi-channel data and learning supervised features. Along with the pivotal clinical features, we finally train a support vector machine to predict if the patient has a long or short overall survival (OS) time. Experimental results demonstrate that our methods can achieve an accuracy as high as 89.9% We also find that the learned features from fMRI and DTI play more important roles in accurately predicting the OS time, which provides valuable insights into functional neuro-oncological applications.

Entities:  

Mesh:

Year:  2016        PMID: 28149967      PMCID: PMC5278791          DOI: 10.1007/978-3-319-46723-8_25

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  6 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Clinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas.

Authors:  Jay J Pillai; Domenico Zacá
Journal:  World J Clin Oncol       Date:  2011-12-10

3.  MR imaging correlates of survival in patients with high-grade gliomas.

Authors:  Whitney B Pope; James Sayre; Alla Perlina; J Pablo Villablanca; Paul S Mischel; Timothy F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

4.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Authors:  M Lacroix; D Abi-Said; D R Fourney; Z L Gokaslan; W Shi; F DeMonte; F F Lang; I E McCutcheon; S J Hassenbusch; E Holland; K Hess; C Michael; D Miller; R Sawaya
Journal:  J Neurosurg       Date:  2001-08       Impact factor: 5.115

5.  Survival analysis of patients with high-grade gliomas based on data mining of imaging variables.

Authors:  E I Zacharaki; N Morita; P Bhatt; D M O'Rourke; E R Melhem; C Davatzikos
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

6.  Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease?

Authors:  S Bisdas; M Kirkpatrick; P Giglio; C Welsh; M V Spampinato; Z Rumboldt
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-29       Impact factor: 3.825

  6 in total
  42 in total

1.  Pre-operative Overall Survival Time Prediction for Glioblastoma Patients Using Deep Learning on Both Imaging Phenotype and Genotype.

Authors:  Zhenyu Tang; Yuyun Xu; Zhicheng Jiao; Junfeng Lu; Lei Jin; Abudumijiti Aibaidula; Jinsong Wu; Qian Wang; Han Zhang; Dinggang Shen
Journal:  Med Image Comput Comput Assist Interv       Date:  2019-10-10

2.  Convolutional Invasion and Expansion Networks for Tumor Growth Prediction.

Authors:  Ling Zhang; Le Lu; Ronald M Summers; Electron Kebebew; Jianhua Yao
Journal:  IEEE Trans Med Imaging       Date:  2018-02       Impact factor: 10.048

3.  Deep Learning of Static and Dynamic Brain Functional Networks for Early MCI Detection.

Authors:  Tae-Eui Kam; Han Zhang; Zhicheng Jiao; Dinggang Shen
Journal:  IEEE Trans Med Imaging       Date:  2019-07-17       Impact factor: 10.048

4.  Modeling multi-species RNA modification through multi-task curriculum learning.

Authors:  Yuanpeng Xiong; Xuan He; Dan Zhao; Tingzhong Tian; Lixiang Hong; Tao Jiang; Jianyang Zeng
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

Review 5.  Current Applications and Future Impact of Machine Learning in Radiology.

Authors:  Garry Choy; Omid Khalilzadeh; Mark Michalski; Synho Do; Anthony E Samir; Oleg S Pianykh; J Raymond Geis; Pari V Pandharipande; James A Brink; Keith J Dreyer
Journal:  Radiology       Date:  2018-06-26       Impact factor: 11.105

6.  DEEP CONVOLUTIONAL NEURAL NETWORKS FOR IMAGING DATA BASED SURVIVAL ANALYSIS OF RECTAL CANCER.

Authors:  Hongming Li; Pamela Boimel; James Janopaul-Naylor; Haoyu Zhong; Ying Xiao; Edgar Ben-Josef; Yong Fan
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2019-07-11

7.  Intelligent inverse treatment planning via deep reinforcement learning, a proof-of-principle study in high dose-rate brachytherapy for cervical cancer.

Authors:  Chenyang Shen; Yesenia Gonzalez; Peter Klages; Nan Qin; Hyunuk Jung; Liyuan Chen; Dan Nguyen; Steve B Jiang; Xun Jia
Journal:  Phys Med Biol       Date:  2019-05-29       Impact factor: 3.609

8.  Automatic Organ Segmentation for CT Scans Based on Super-Pixel and Convolutional Neural Networks.

Authors:  Xiaoming Liu; Shuxu Guo; Bingtao Yang; Shuzhi Ma; Huimao Zhang; Jing Li; Changjian Sun; Lanyi Jin; Xueyan Li; Qi Yang; Yu Fu
Journal:  J Digit Imaging       Date:  2018-10       Impact factor: 4.056

9.  Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas.

Authors:  W Han; L Qin; C Bay; X Chen; K-H Yu; N Miskin; A Li; X Xu; G Young
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-19       Impact factor: 3.825

10.  Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages.

Authors:  Dong Nie; Junfeng Lu; Han Zhang; Ehsan Adeli; Jun Wang; Zhengda Yu; LuYan Liu; Qian Wang; Jinsong Wu; Dinggang Shen
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.